In this video, Andrew J. Armstrong, MD, MSc, discusses new data from the ARCHES trial
Expert panelists center discussion around two patient cases to review use of newer anti-androgen deprivation therapy in the management of prostate cancer.
In this interview, Stephen J. Savage, MD, discusses current research he’s working on, the role of molecular testing in prostate cancer as well as unmet needs in treating the disease.
A majority of subsequent biopsies performed in men with negative mpMRI results showed tumors of equal or lesser grade.
In a study, men with PSA bounce had a lower PSA nadir and longer time to PSA nadir than men who had biochemical recurrence.
Mark C. Markowski, MD, PhD, discusses the safety and efficacy of sabizabulin in a phase 1b/2 trial in metastatic castration-resistant prostate cancer.